American College of Gastroenterology Responds to 'The $2.7T Medical Bill'

American College of Gastroenterology Responds to ‘The $2.7T Medical Bill’

Ronald Vender, MD, board-certified gastroenterologist and president of the American College of Gastroenterology, recently wrote a letter responding to “The $2.7 Trillion Medical Bill” article that included colonoscopy as a leading cause of high medical costs, according to a report by The New York Times.

Dr. Vender writes that the article fails to take into account the benefits of colonoscopy, which has demonstrated the ability to prevent and reduce the number of fatal colon cancer cases.

Dr. Vender and the American College of Gastroenterology remain convinced colonoscopy is a vital tool for the screening of colon cancer.

More Articles on Gastroenterology:
Canon Launches New Cambridge Research Location, To Study Endoscopy
Dr. Leslie Schoppe Joins Brownwood Regional Medical Center
UHC Recruits Dr. Adam Hansen, Gastroenterology Specialists

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Next Up in GI & Endoscopy

American College of Gastroenterology Responds to ‘The $2.7T Medical Bill’

Building a High-Performance Cardiac PET Program: What Health Systems Should Consider

Next Up in GI & Endoscopy

GI groups push back on White House rule that would give political appointees power over NIH grants

Fresh off a $3.9B close, Amsurg adds 5 GI centers in North Carolina

FDA approves 2nd blood-based CRC screening test

Building a High-Performance Cardiac PET Program: What Health Systems Should Consider

Next Up in GI & Endoscopy

GI groups push back on White House rule that would give political appointees power over NIH grants

Fresh off a $3.9B close, Amsurg adds 5 GI centers in North Carolina

FDA approves 2nd blood-based CRC screening test

Join the 40,000+ ASC leaders who start their day with Becker's